🚨 Dr. William Makis just dropped his updated Ivermectin & Fenbendazole Cancer Protocol. And people are losing their minds. Not because it's controversial. Because it gives real answers. Here's the truth: Most protocols treat every cancer the same. Dr. Makis says that's a mistake. A patient in remission ≠ a patient with widespread metastases. A slow-growing tumor ≠ aggressive brain cancer. So he designed FOUR dosing levels. Not one. Four. 👇 🟢 LOW DOSE Ivermectin: ≤ 0.5 mg/kg – 3x per week Fenbendazole: 222 mg/day – 3 days on, 4 off Best for: Remission support, prevention, strong family history, higher risk individuals. 🟡 MEDIUM DOSE Ivermectin: 1.0 mg/kg – daily Fenbendazole: 222 mg/day – 6 days per week Best for: Most active cancers – common starting approach. 🔵 HIGH DOSE Ivermectin: 2.0 mg/kg – daily Fenbendazole: 444 mg/day – 6 days per week Best for: Aggressive cancers, brain cancer, leukemia, pancreatic cancer. 🔴 VERY HIGH DOSE Ivermectin: ≥ 2.5 mg/kg – daily Fenbendazole: 888-1000 mg/day – 6 days per week Best for: Extensive metastatic disease, poor prognosis cases. 💡 Why is this different? It's not about the numbers. It's about the thinking behind them. Dr. Makis believes cancer isn't one disease. It's many. And a one-size-fits-all approach? That doesn't always make sense. 🔬 The research is growing. Ivermectin and Fenbendazole are being studied for how they interact with: • Cancer metabolism • Cancer stem cells • Mitochondrial function • Tumor signaling pathways • Treatment resistance mechanisms • Cellular energy production One thing is undeniable: More cancer patients, caregivers, and researchers are talking about repurposed medicines today than ever before. And that's exactly why charts like this keep getting shared. 📌 Save this chart. Six months from now, you'll wish you knew where to find it. 🔁 Repost it. Someone researching cancer protocols needs to see this.